3 Growth Stocks That Could Go Even Higher in 2025 and Beyond
Many high-growth stocks rallied over the past year in expectation of lower interest rates, boosting their stock prices and their valuations in the process. But because of those gains, some investors might be wary of chasing those highfliers now, especially as the real potential for new tariffs and trade conflicts threaten to end the current bull market (which started in October 2022).
Long-term investors shouldn't be afraid to invest in top tech companies that have plenty of room to grow over the next few decades. I believe these three long-term winners are still worth buying in this frothy market: ServiceNow (NYSE: NOW), Toast (NYSE: TOST), and Affirm (NASDAQ: AFRM). Here's why.
ServiceNow's cloud-based digital workflow platform cleans up unstructured work patterns and makes it easier for companies to expand efficiently, cut costs, and provide better support for their hybrid and remote workers. Its Now Assist AI platform further accelerates that process with AI-powered chatbots and automation tools for employees.
Its business model is well insulated from the macroeconomic headwinds since many companies use its tools to streamline their operations during economic downturns. Its adjusted revenue rose 23.5% in 2023 and 22.5% in 2024, and analysts expect it to grow at a compound annual growth rate (CAGR) of 19% over the next three years. It's also profitable on a generally accepted accounting principles (GAAP) basis, and analysts expect its earnings per share (EPS) to grow at a CAGR of 28% from 2024 to 2027.
ServiceNow expects its long-term growth to be driven by new government contracts and the rising usage of Now Assist's AI tools. During its latest conference call in January, CEO Bill McDermott called his company the "control tower for AI transformation" and said it's clear its "AI platform message is landing, and it's scaling."
ServiceNow's stock might not seem cheap at 15 times this year's sales, but it's poised to grow over the next few decades. Its ecosystem is sticky, it's resistant to recessions, and it's well exposed to the booming cloud and AI markets.
Toast sells point-of-sale (POS) payment systems, guest-facing and kitchen displays, and cloud-based services for managing payrolls, loyalty plans, online orders, and reservations. Simply put, it's a one-stop shop for digitizing a restaurant.
Toast served 48,000 restaurants when it went public in 2021, but that figure had grown to nearly 127,000 restaurants in its latest quarter. It expanded even as the pandemic and inflation disrupted the restaurant industry over the past five years.
To keep growing, Toast is expanding its higher-margin subscription services and financial technology solutions segment (which provides its ancillary services) to reduce its dependence on its low-margin payment processing fees. It also streamlined its business with major rounds of layoffs in 2020 and 2024, and it continues to cut its other expenses.
Toast's revenue rose 60% in 2022 and 42% in 2023, and analysts expect its revenue to grow at a CAGR of 24% from 2023 to 2026 as its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rises at a CAGR of 129%. Its business is gradually maturing, but it could still have plenty of room to grow as it digitizes more brick-and-mortar restaurants. That's a bright outlook for a stock that trades at just 4 times next year's sales.
Affirm is a top provider of buy now, pay later (BNPL) services. It splits purchases into smaller installment plans through "microloans," which are attractive options for younger or lower-income consumers who can't get approved for credit cards.
It doesn't charge any interest on payments split into four installments, and it doesn't charge any compound interest or hidden fees for any of its payments. It's also an attractive payment option for big merchants, which can often negotiate lower BNPL fees than the 1.5% to 3.5% swipe fees charged by most credit card networks.
Affirm's revenue only rose 18% in fiscal 2023 (which ended in June 2023) as it lapped its pandemic-driven growth spurt and faced tougher inflationary headwinds. But in fiscal 2024, its revenue grew 46% as it gained more merchants, issued its Affirm Card (which combines a debit card with BNPL options) to more consumers, and benefited from higher travel and general merchandise sales. By the end of its latest quarter, its loans that were delinquent for over 30 days held steady at just 2.8%.
From fiscal 2024 to fiscal 2027, analysts expect Affirm's revenue to grow at a CAGR of 28% as the macro environment stabilizes again. Its adjusted EBITDA is also expected to turn positive in fiscal 2025 and grow at a CAGR of 327% over the following two years. It might not seem cheap at 10 times this year's sales, but it could be a great long-term play on the secular expansion of the nascent BNPL market and the disruption of traditional credit cards.
Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this.
On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves:
Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $361,026!*
Apple: if you invested $1,000 when we doubled down in 2008, you'd have $46,425!*
Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $562,659!*
Right now, we're issuing 'Double Down' alerts for three incredible companies, and there may not be another chance like this anytime soon.*Stock Advisor returns as of February 3, 2025
Leo Sun has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ServiceNow and Toast. The Motley Fool has a disclosure policy.
3 Growth Stocks That Could Go Even Higher in 2025 and Beyond was originally published by The Motley Fool
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
‘Still Not a Bargain,' Says Top Investor About Nike Stock
'Just Do It,' goes the motto that Nike (NYSE:NKE) made a household catchphrase. With its branded 'Swoosh' and world-famous spokespeople, it is no stretch to argue that Nike helped to build the premium shoe market — one that grew by leaps and bounds earlier this decade. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Indeed, the COVID years saw a major spike in Nike's footwear sales – from $23.3 billion in 2020 to over $35 billion in 2023 – though growth has been slowing of late. Last year saw footwear revenues decrease slightly, and its share price has fallen almost 40% during the past twelve months. This week, Nike will be releasing its FQ4 2025 results, and consensus estimates are not exactly bullish. Analysts are expecting total revenues of $10.7 billion – down 15% year-over-year – while a projected EPS of $0.12 would represent an 89% decrease year-over-year. One top investor known by the pseudonym Stone Fox Capital thinks that the growing competition will continue to present stiff resistance going forward. 'Nike remains overvalued despite a significant price decline, with the market underestimating downside risks and ongoing competitive pressures,' explains the 5-star investor, who is among the top 3% of TipRanks' stock pros. The biggest challenge for Nike going forward will be the growing competition, asserts Stone Fox Capital, citing On Holding and HOKA as two of the biggest threats. For instance, ONON's On Running is expected to grow revenues by 40% this year. Still, NKE is trading 'at multiples above the market,' despite forecasts of stagnating growth going forward. Stone Fox Capital spots quite a disconnect – one that the market has yet to take fully into account. 'Nike should be viewed based on the readily available data of a massive athletic footwear company that hasn't grown in years facing immense competition,' adds Stone Fox Capital. Stone Fox Capital is urging investors to pay attention to upcoming guidance for the next quarter, which the investor predicts will be a 'horrible' forecast. Needless to say, Stone Fox Capital does not believe that 'Just Do It' is good advice for would-be investors at present. 'The stock might be down substantially from the all-time highs a few years ago, but Nike isn't actually trading like the business is under pressure,' concludes Stone Fox Capital, who rates NKE a Sell. (To watch Stone Fox Capital's track record, click here) Wall Street is overall positive when it comes to Nike, though not overwhelmingly. With 12 Buy and 11 Hold ratings, NKE is a consensus Moderate Buy. Its 12-month average price target of $71.24 has an upside of ~19%. (See NKE stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
4 hours ago
- Yahoo
Better Cybersecurity Stock: CrowdStrike or SentinelOne?
CrowdStrike and SentinelOne have similar business models and offerings. CrowdStrike is much larger. SentinelOne trades at a steep discount to CrowdStrike. 10 stocks we like better than CrowdStrike › Artificial intelligence (AI) may have many benefits, but it's also making it easier for hackers, online criminals, and other digital malefactors to threaten businesses, and those threats are getting more potent. Keeping them at bay requires a lot of funds to be devoted to cybersecurity, making companies like CrowdStrike (NASDAQ: CRWD) and SentinelOne (NYSE: S) excellent investment opportunities. But is there an advantage to buying one over the other now? Both companies' base products are AI-powered protection platforms that analyze digital activity and learn to spot the threats among the normal activity. They deploy their software to network endpoints -- in other words, laptops, smartphones, and other devices that can access a client's internal network. By protecting these devices, companies make it harder for cyberattackers to gain access to their internal networks, where they might steal sensitive information, delete files, interfere with systems, or even lock them down with ransomware to extort payments from their victims. While endpoint protection is how both companies land clients, each bolsters its offerings with an array of other cybersecurity products that clients can use to create a protection suite tailored to their unique situations. Since these two direct competitors offer highly similar product types, it's hard to declare either a winner on this front from an investor perspective. Winner: Tie. From a sheer size perspective, CrowdStrike is the clear winner. During its fiscal 2026 first quarter, which ended April 30, CrowdStrike's annual recurring revenue (ARR) rose to $4.4 billion. SentinelOne's ARR of $948 million in its fiscal Q1 was less than a quarter of that. While size doesn't always matter, in this case, it does. Because so many more companies use CrowdStrike's platform, it's more likely that any given IT professional will have at least one contact already on its client list. If CrowdStrike is doing a great job with those clients, word will spread, and it will likely receive more serious consideration in future cybersecurity bidding processes. This advantage cannot be understated. Indeed, it's one of the reasons why CrowdStrike's growth has remained strong despite its size. Winner: CrowdStrike In terms of growth rates, SentinelOne is slightly outperforming CrowdStrike in this category. However, this should be no surprise because SentinelOne is a much smaller company. In fiscal Q1, SentinelOne's ARR rose 24% year over year, while CrowdStrike's increased 22% year over year. While I will give the point to SentinelOne, it's important to understand that CrowdStrike is growing from a much larger base than SentinelOne, making this close call all the more impressive for CrowdStrike. Winner: SentinelOne Due to its smaller size and focus on top-line growth, SentinelOne is far from profitable, while CrowdStrike has achieved intermittent profitability (although it reverted to a negative operating margin and a loss in its most recent quarter). SentinelOne is far from breaking even, but CrowdStrike was in this same position about five years ago. There's no reason not to expect SentinelOne to follow a similar path to profitability, but it will take some time. Meanwhile, CrowdStrike should eventually turn a profit again, as it has proven that it can do that. Winner: CrowdStrike CrowdStrike is leading this battle of the stocks so far, but SentinelOne is about to change the narrative with one jaw-dropping metric. CrowdStrike is the most popular cybersecurity stock in the market, and as a result, it has been bid up to expensive levels. From a price-to-sales (P/S) standpoint (the best metric to use to compare these companies since CrowdStrike flips between profitable and unprofitable, while SentinelOne is years away from profits), CrowdStrike has gotten far more expensive than SentinelOne over the past few years. CrowdStrike stock is now five times more expensive than SentinelOne, which is hard to believe, considering they compete in the same industry and are growing at nearly identical rates. This leads me to believe that CrowdStrike's stock has been overly hyped up while SentinelOne has been forgotten. While I'm OK with valuing CrowdStrike at a premium due to its market leadership position, this is far too great a premium to pay. SentinelOne is a dirt-cheap stock, and CrowdStrike is almost too expensive to consider. While I have been a long-term CrowdStrike bull, I'd be a bit cautious about buying the stock at its current lofty valuation. As a result, I think SentinelOne is the better cybersecurity investment right now. Before you buy stock in CrowdStrike, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and CrowdStrike wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Keithen Drury has positions in CrowdStrike. The Motley Fool has positions in and recommends CrowdStrike. The Motley Fool has a disclosure policy. Better Cybersecurity Stock: CrowdStrike or SentinelOne? was originally published by The Motley Fool Sign in to access your portfolio
Business Upturn
5 hours ago
- Business Upturn
OGN FRAUD ALERT: Organon & Co. Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by July 22 Legal Deadline (NYSE:OGN)
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting Investors have until July 22, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Organon securities. The case is pending in the U.S. District Court for the District of New Jersey and is captioned: Hauser v. Organon & Co., et al. , No. 25-cv-05322. Why was Organon Sued for Securities Fraud? Organon is a global healthcare company focused on women's health that has historically rewarded its shareholders with a healthy dividend. In October 2024, Organon completed a $1.2 billion acquisition of Dermavant, a biopharmaceutical company focused on dermatological conditions. As alleged, while the acquisition increased Organon's debt, the Company assured investors it would maintain its dividend, which Organon asserted was its '#1 capital allocation priority.' In truth, Organon had shifted its capital allocation priority after the Dermavant acquisition to focus on reducing its debt, ultimately leading the Company to severely cut its dividend. The Stock Declines as the Truth is Revealed On May 1, 2025, Organon announced that management reset the Company's dividend payout from $0.28 per share to $0.02 per share. Organon's CEO explained that the Company 'reset our capital allocation priorities to accelerate progress towards deleveraging' and that '[b]y deleveraging more rapidly, we will continue to strengthen the future prospects of the company.' Organon's CFO added, '[t]he biggest issues we face . . . relate to managing our leverage and relate to growth. And we need capital to solve both of those issues, and so returning capital to shareholders is right now, less of a priority.' On this news, the price of Organon stock declined roughly 27%, from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025. Click here if you suffered losses: What Can You Do? If you invested in Organon you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
